Results 161 to 170 of about 23,768 (220)

Physical activity in Parkinson's disease: examining prescription sources, patterns, and the influence of quality of life and disease severity. [PDF]

Rev Neurol
Suárez-Iglesias D, Diz JC, Bidaurrazaga-Letona I, Ayán C.   +3 more
europepmc   +1 more source

Parkinson disease treatments on national essential medicines lists, African Region. [PDF]

Bull World Health Organ
Fothergill-Misbah N, Cataldi R, Stothard M, Chowdhary N, Okubadejo N, Cappello B, Walker R, Dua T.   +7 more
europepmc   +1 more source

Enfermedad de parkinson II

Evidencia. Actualización en la Práctica Ambulatoria, 2005
Augusto Granel
doaj   +1 more source

Estimating the prevalence, factors, and conditions associated with Parkinson disease: a population-based study in Peru. [PDF]

Cad Saude Publica
Bernabe-Ortiz A, Carrillo-Larco RM.
europepmc   +1 more source

[Psychosocial strategies to strengthen the coping with Parkinson's disease: Perspectives from patients, family carers and healthcare professionals]. [PDF]

Aten Primaria, 2017
Navarta-Sánchez MV, Caparrós N, Ursúa Sesma ME, Díaz de Cerio Ayesa S, Riverol M, Portillo MC.   +5 more
europepmc   +1 more source

[Key messages to promote positive living with Parkinson's disease in the community]. [PDF]

Aten Primaria, 2015
Portillo MC, Ursúa Sesma ME, Díaz de Cerio Ayesa S, grupo investigador Programa ReNACE.   +3 more
europepmc   +1 more source

¿Qué nos enseñan los modelos animales y celulares sobre la enfermedad de Parkinson? [PDF]

, 2013
López Barneo, José
core  

Parkinson y pesticidas. [PDF]

, 2012
García Martínez, Cristina
core   +1 more source

[Continuous Subcutaneous Apomorphine Infusion Therapy: Economic Impact in Spain]. [PDF]

Rev Neurol
Micolta-Córdoba L, Castro-Ramirez JP, Reyes-Ortiz C.   +2 more
europepmc   +1 more source

[Wolff-Parkinson-White syndrome due to cocaine use: a case report]. [PDF]

Rev Med Inst Mex Seguro Soc
Lara-Duck MF, Rosales-Martínez J, Mayek-Pérez N.   +2 more
europepmc   +1 more source